Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
890.7 USD | -1.75% | -0.37% | +1.41% |
Apr. 25 | Regeneron Pharmaceuticals Receives a Shareholder Proposal from John Chevedden | CI |
Apr. 25 | Regeneron Sets Crispr-Based Collaboration With Mammoth Biosciences | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.41% | 97.42B | |
-2.26% | 104B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B | |
-26.18% | 8.22B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals : Credit Suisse Lowers Regeneron Pharmaceuticals' Price Target to $753 From $758, Keeps Outperform Rating